1. Pediatr Rheumatol Online J. 2015 Sep 7;13(1):37. doi:
10.1186/s12969-015-0035-7.

Severe immune dysregulation with neurological impairment and minor bone changes 
in a child with spondyloenchondrodysplasia due to two novel mutations in the 
ACP5 gene.

Girschick H(1), Wolf C(2), Morbach H(3), Hertzberg C(4), Lee-Kirsch MA(5).

Author information:
(1)Children's Hospital, Vivantes Hospital im Friedrichshain, Berlin, Germany. 
Hermann.Girschick@vivantes.de.
(2)Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische 
Universität Dresden, Dresden, Germany. christine.wolf@uniklinikum-dresden.de.
(3)Department of Pediatrics, University Clinics of Würzburg, Würzburg, Germany. 
Morbach_H@ukw.de.
(4)Socialpediatric Centre, Children's Hospital, Vivantes Hospital Neukölln, 
Berlin, Germany. Christoph.Hertzberg@vivantes.de.
(5)Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische 
Universität Dresden, Dresden, Germany. minae.lee-kirsch@uniklinikum-dresden.de.

Spondyloenchondrodysplasia (SPENCD) is a rare skeletal dysplasia, characterized 
by metaphyseal lesions, neurological impairment and immune dysregulation 
associated with lupus-like features. SPENCD is caused by biallelic mutations in 
the ACP5 gene encoding tartrate-resistant phosphatase. We report on a child, who 
presented with spasticity, multisystem inflammation, autoimmunity and 
immunodeficiency with minimal metaphyseal changes due to compound heterozygosity 
for two novel ACP5 mutations. These findings extend the phenotypic spectrum of 
SPENCD and indicate that ACP5 mutations can cause severe immune dysregulation 
and neurological impairment even in the absence of metaphyseal dysplasia.

DOI: 10.1186/s12969-015-0035-7
PMCID: PMC4562156
PMID: 26346816 [Indexed for MEDLINE]